|
|
 |
COPOVIDONE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CLENPIQ Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
COPIKTRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CYSTEINE HYDROCHLORIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CHLOROCRESOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
COLLOIDAL SILICON DIOXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|